| Single isocenter stereotactic radiosurgery for patients with multiple brain metastases: dosimetric comparison of VMAT and a dedicated DCAT planning tool J Hofmaier, R Bodensohn, S Garny, I Hadi, DF Fleischmann, M Eder, ... Radiation Oncology 14, 1-8, 2019 | 51 | 2019 |
| Stereotactic radiosurgery combined with targeted/immunotherapy in patients with melanoma brain metastasis I Hadi, O Roengvoraphoj, R Bodensohn, J Hofmaier, M Niyazi, C Belka, ... Radiation Oncology 15, 1-11, 2020 | 37 | 2020 |
| A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients R Bodensohn, S Corradini, U Ganswindt, J Hofmaier, O Schnell, C Belka, ... International journal of clinical oncology 21, 642-650, 2016 | 33 | 2016 |
| Structured reporting has the potential to reduce reporting times of dual-energy x-ray absorptiometry exams SH Kim, LM Sobez, JE Spiro, A Curta, F Ceelen, E Kampmann, ... BMC musculoskeletal disorders 21, 1-10, 2020 | 27 | 2020 |
| Multifocal high-grade glioma radiotherapy safety and efficacy DF Fleischmann, R Schön, S Corradini, R Bodensohn, I Hadi, J Hofmaier, ... Radiation Oncology 16 (1), 165, 2021 | 22 | 2021 |
| Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis R Bodensohn, I Hadi, DF Fleischmann, S Corradini, N Thon, J Rauch, ... Strahlentherapie und Onkologie 196, 70-76, 2020 | 22 | 2020 |
| Stereotactic radiosurgery versus whole-brain radiotherapy in patients with 4–10 brain metastases: A nonrandomized controlled trial R Bodensohn, AL Kaempfel, AL Boulesteix, AM Orzelek, S Corradini, ... Radiotherapy and Oncology 186, 109744, 2023 | 20 | 2023 |
| MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience I Hadi, C Eze, S Schönecker, R von Bestenbostel, P Rogowski, L Nierer, ... Radiation Oncology 17 (1), 8, 2022 | 20 | 2022 |
| Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial R Bodensohn, AL Kaempfel, DF Fleischmann, I Hadi, J Hofmaier, S Garny, ... Strahlentherapie und Onkologie 197, 601-613, 2021 | 18 | 2021 |
| Hippocampal EUD in primarily irradiated glioblastoma patients R Bodensohn, M Söhn, U Ganswindt, G Schupp, SB Nachbichler, ... Radiation Oncology 9, 1-9, 2014 | 16 | 2014 |
| MRI-based contrast clearance analysis shows high differentiation accuracy between radiation-induced reactions and progressive disease after cranial radiotherapy R Bodensohn, R Forbrig, S Quach, J Reis, AL Boulesteix, U Mansmann, ... ESMO open 7 (2), 100424, 2022 | 14 | 2022 |
| Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome I Hadi, A Biczok, N Terpolilli, J Thorsteinsdottir, R Forbrig, NL Albert, ... Neuro-Oncology Advances 3 (1), vdab114, 2021 | 11 | 2021 |
| Erstmalige interdisziplinäre DKK-Programmplanung durch Zusammenschluss onkologischer Nachwuchsgruppen MA Mäurer, T Huber, NP Sommer, I Mäurer, L Lazaridis, R Bodensohn, ... Forum 37 (1), 19-23, 2022 | 9 | 2022 |
| Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques R Bodensohn, SH Maier, C Belka, G Minniti, M Niyazi Cancers 15 (22), 5404, 2023 | 6 | 2023 |
| Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity … R Bodensohn, S Werner, J Reis, MP Escudero, AL Kaempfel, I Hadi, ... Clinical and Translational Radiation Oncology 39, 100573, 2023 | 6 | 2023 |
| Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas I Hadi, D Reitz, R Bodensohn, O Roengvoraphoj, S Lietke, M Niyazi, ... Radiation oncology 16, 1-9, 2021 | 6 | 2021 |
| Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12) R Bodensohn, DF Fleischmann, SH Maier, V Anagnostatou, S Garny, ... Clinical and Translational Radiation Oncology 45, 100706, 2024 | 5 | 2024 |
| Postoperative [68Ga]Ga-DOTA-TATE PET/CT imaging is prognostic for progression-free survival in meningioma WHO grade 1 N Teske, A Biczok, S Quach, FJ Dekorsy, R Forbrig, R Bodensohn, ... European journal of nuclear medicine and molecular imaging 51 (1), 206-217, 2023 | 4 | 2023 |
| Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin’s lymphoma: a monocenter analysis I Hadi, A Schummer, M Dreyling, C Eze, R Bodensohn, O Roengvoraphoj, ... Scientific reports 11 (1), 22586, 2021 | 4 | 2021 |
| FET PET-based target volume delineation for the radiotherapy of glioblastoma: A pictorial guide to help overcome methodological pitfalls A Holzgreve, A Nitschmann, SH Maier, M Büttner, S Schönecker, ... Radiotherapy and Oncology, 110386, 2024 | 3 | 2024 |
Stefanie CorradiniMD在 med.uni-muenchen.de 的电子邮件经过验证
